Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Evotec signs high-throughput screening deal with Alios Biopharma
August 2009
SHARING OPTIONS:

HAMBURG, GermanyŚEvotec AG, a leading provider in the discovery and development of novel small-molecule drugs, announced in July a collaboration with Alios Biopharma Inc. in which Evotec will use its proprietary ultra-high-throughput platform and technology to screen a priority biological target for Alios. In addition, Alios will access Evotec's high quality small molecule screening library for the screen. No financial details or specific information on Alios' target were disclosed. 

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.